MTOR and lymphangioleiomyomatosis: reported that estrogen-ERK2 pathway activated mTOR pathway by enhancing the effect of late response-gene Fra1. Oberstein et al. [23] also suggested that oral contraceptive pills, which contain high levels of estrogen, serve as catalysts to promote the occurrence of LAM.